Evidence map›Paper›PMID 25632374›Full record

ArticleJournal of obesity & weight loss therapy2013

25-Hydroxyvitamin D Supplementation and BMI Change: A Meta-Analysis of Randomized Controlled Trials.

N Mora, K Rieke, J Plitcha, Aj Segura, D Leehey, K DeShong, H Kramer, Ramon A Durazo-Arvizu

Abstract read
In one paragraph

Article in Journal of obesity & weight loss therapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

N MoraPublic Health Program, Loyola University Chicago Health Sciences Center, Chicago, Illinois, USA.
K RiekePublic Health Program, Loyola University Chicago Health Sciences Center, Chicago, Illinois, USA.
J PlitchaDepartments of Surgery, Loyola University Chicago Health Sciences Center, Chicago, Illinois, USA.
Aj SeguraPublic Health Program, Loyola University Chicago Health Sciences Center, Chicago, Illinois, USA.
D LeeheyMedicine, Division of Nephrology and Hypertension, Loyola University Chicago Health Sciences Center, Chicago, Illinois, USA.
K DeShongPublic Health Program, Loyola University Chicago Health Sciences Center, Chicago, Illinois, USA.
H KramerPublic Health Program, Loyola University Chicago Health Sciences Center, Chicago, Illinois, USA ; Medicine, Division of Nephrology and Hypertension, Loyola University Chicago Health Sciences Center, Chicago, Illinois, USA ; Department of Preventive Medicine and Epidemiology, Loyola University Chicago Health Sciences Center, Chicago, Illinois, USA.
Ramon A Durazo-ArvizuPublic Health Program, Loyola University Chicago Health Sciences Center, Chicago, Illinois, USA ; Department of Preventive Medicine and Epidemiology, Loyola University Chicago Health Sciences Center, Chicago, Illinois, USA.

Funding

Determinants and Consequences of Low Vitamin D in Populations of African DescentR01DK090360 · NIDDK · LOYOLA UNIVERSITY CHICAGO · PI DURAZO-ARVIZU, RAMON ANGEL · 2011 to 2015
$3.0M
NIDDK NIH HHS R01 DK090360
6 · The paper itself

Abstract

The impact of 25-hydroxyvitamin D (25[OH]D) supplementation on weight change remains controversial. The objective of this study was to summarize the effects of 25[OH]D supplementation (cholecalciferol or ergocalciferol) on BMI change through a meta-analysis of published clinical trials. We completed a systematic review of English articles, using MEDLINE (Ovid, Pubmed) from January 1, 1998 through January 1, 2013. The articles selected focused on 25[OH]D supplementation and body mass index (BMI) in randomized controlled trials (RCT's). The association between 25[OH]D and mean BMI change was estimated utilizing a random effects model. A total of 30 studies were reviewed and 9 were included in the meta-analysis. Total participants included 1651 adults (82.6% women and mean age 47.9 years) and mean follow-up ranged between 6 to 196 weeks and mean daily 25[OH]D dose ranged from 200 IU to 1,110 IU. Five of the 9 studies included calcium supplementation in both groups. Average baseline BMI was 30.7 and 30.4 kg/m

Indexed as

25-hydroxyvitamin D (25[OH]D)Body Mass Index (BMI)Meta-analysisObesityVitamin D

Identifiers

PMID25632374
PMCPMC4306432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.